跳至主要内容
临床试验/NCT02040025
NCT02040025终止不适用

Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus

David Grant U.S. Air Force Medical Center1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
2
试验地点
1
主要终点
Change from baseline in TCOM (Transcutaneous oximetry measurement) values

研究概览

简要总结

The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age equal to or greater than 18
  • Diagnosis of Type 1 or Type 2 diabetes mellitus
  • Prescribed EECP therapy in the DGMC EECP clinic
  • Medically cleared for EECP therapy
  • TRICARE beneficiary

排除标准

  • DGMC EECP clinic patient withou a diagnosis of Type 1 or Type 2 diabetes mellitus

结局指标

主要结局

Change from baseline in TCOM (Transcutaneous oximetry measurement) values

时间窗: At baseline & post intervention, expected to be on average 30 minutes

次要结局

  • Change from baseline in hemoglobin A1C laboratory values(At baseline & post intervention, expected to be on average 30 minutes)

研究者

发起方
David Grant U.S. Air Force Medical Center
申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluating the Effects of EECP on Circulation, Blood... | 临床试验